To the Editor: Adherence to clinical guidelines for HIV-specific management in Australia is relatively good in international terms, but the screening for and management of comorbid conditions and risk factors is far less comprehensive.1-3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Bloch M, Hoy J, Cunningham N, et al. Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapy. J Acquir Immune Defic Syndr 2012; 59: 478-488.
- 2. Broom J, Sowden D, Williams M, et al. Moving from viral suppression to comprehensive patient-centered care: the high prevalence of comorbid conditions and health risk factors in HIV-1-infected patients in Australia. J Int Assoc Physicians AIDS Care (Chic) 2012; 11: 109-114.
- 3. Kelly MD, Broom JK, Young S. The use of key performance indicators to benchmark individual clinic performance in managing a complex chronic infectious disease. Med J Aust 2012; 197: 330-331. <MJA full text>
- 4. Rotter T, Kinsman L, James E, et al. The quality of the evidence base for clinical pathway effectiveness: room for improvement in the design of evaluation trials. BMC Med Res Methodol 2012; 12: 80.
- 5. Malhotra Y, Singh S, Brook MG. The use of an electronic checklist in the electronic patient record to achieve annually recommended outcomes based on British HIV Association guidelines. Int J STD AIDS 2012; 23: 516-517.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We thank the Queensland HIV Care Plan working group for developing and distributing the HAC; Merran Williams for auditing; and the clinical staff at Clinic 87, Nambour for their assistance.
No relevant disclosures.